We are hiring a Clinical Research Nurse or Clinical Research Practitioner! We have two posts available based in London and Manchester to work on the upcoming FORWARDS-2 trial. Please RT.
London site: https://t.co/pc787PtTVD
Manchester site: https://t.co/CxuTiTECtF
We won!
Our Addiction Team received the Reward and Recognition Award for the category Public Engagement for our contributions to the Imperial Lates: Drug Experiments event.
It was a great evening and we were all buzzing afterwards!
Thank you to everyone who came along!
Tonight on BBC1 @mattjwillis shares his experience of addiction and the impact on his loved ones. Tune in at 9pm to see him chat with @DrLMPaterson about the work we’re doing and how it may help those affected.
https://t.co/riBYl5mITl
We had a great time today at the #ecraddictions2023 conference presenting our findings from the NCORE & FORWARDS studies. A big congratulations to our very own @DrLMPaterson who won the best oral presentation award!
& thank you to the organisers! @SSA_Addiction@KingsAddictions
Come & join us at the upcoming Imperial Lates event to find out more about drug experiments. We'll be chatting all things substance use & addiction with some great artwork & interactive activities.
Get your free tickets here 👉 https://t.co/Wx7cTAZ2XE
@imperialcollege
One of our PhD students @Dr_K_Herlinger presented her findings on the NCORE study at the @LxAddictions conference last week. Follow the link to read more! https://t.co/2kz8EqCS68 #LxAddictions22
We were at the #ssaconf22 this year! What a great time talking to everyone about their research and learning from each other about the latest developments in addiction research. We look forward to next time! Thank you @SSA_Addiction!
Check out the protocol of our current study FORWARDS-1, an adaptive, single-blind, placebo-controlled ascending dose study of acute baclofen in methadone-maintained opioid dependence.
https://t.co/x6rn9hiyjG
Interesting new paper from our research assistant @joannavamvako looking at the effect of selective D3 antagonism on BOLD response to aversive image processing in drug-dependent individuals.
https://t.co/awkPgpHPwm
@FrontPsychiatry
Dame Carol Black recently visited our lab to find out about our research to improve the understanding and treatment of addiction. If you’re interested, you can read more about her visit here:
https://t.co/lPEq9uMTV4
We’ve been busy this conference season presenting some of our research at @FENSorg, @SOBP@BAPsych - check out our posters looking at all things addiction 🧠 @LexiJHand@LexiHayes17
We're hiring!! 🧠 We are looking for an experienced clinical trials manager to join our multidisciplinary team at Imperial College London. Interested? find out more by following the link.
https://t.co/2Q6pUpBVIt
@ImpPsych@ImperialMed@imperialcollege
The FORWARDS study makes use of a novel, adaptive, dose-finding design to assist with dose escalation decisions. The design of the model has now been published in Pharmaceutical Statistics: the Journal of Applied Statistics in the Pharmaceutical Industry.
https://t.co/6x8nvEXLcZ
Check out our blog post explaining the background and aims of our most recent study - FORWARDS, investigating the safety and proof-of-concept efficacy of baclofen to support detoxification from methadone in opiate dependence.
https://t.co/d1GZ9IC13g
We are still looking for healthy control volunteers for our study NCORE! Are you or is someone you know a current or ex-smoker, 30+ years old and based in Greater London and surrounding areas? Learn more at https://t.co/eD58Exane8 or email us at [email protected]